Authors
Mehran Rezaei-Larijani, Bagher Larijani, Yaser Tahamtani, Hamid Reza Aghayan, Mohammad Kazemi Ashtiani
Published in
Islets. Volume 18. Issue 1. Pages 2763804. Dec 31, 2026. Epub Nov 16, 2026.
Abstract
Insulin-producing cells (IPCs) generated from human pluripotent stem cells (hPSCs) are a promising cell source for β-cell replacement therapy in patients with diabetes. Despite substantial advances, optimizing IPC differentiation efficiency and maturation, as well as long-term functional stability after transplantation, remains challenging. One strategy to enhance IPC function and survival is to utilize native extracellular matrix (ECM) components present within the pancreatic islet niche. ECM components activate intracellular signaling pathways essential for cell adhesion, survival, and insulin gene expression. Researchers have developed various scaffolds to reconstitute these components in vitro. This review integrates current insights into ECM-IPC interactions, focusing on scaffold composition, physical properties, and bioactive modifications that enhance IPC viability and function and discusses how these scaffold properties could improve the outcomes of β-cell replacement therapy in diabetes.
PMID:
43038095
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0